Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01968707 · ClinicalTrials.gov registry record · Phase 3
In-vivo Efficacy Study of Patient Pre-operative Preps
A Phase 3 study, sponsored by Solventum US.
- Completed
- Registry status
- Phase 3
- Development phase
- 426
- Enrollment target
NCT01968707 is a Phase 3 study that has completed, run by Solventum US. The registered enrollment target is 426 participants.
The verdict
NCT01968707, a Phase 3 study, has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 426 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.
Interventions
- DRUG Normal saline
- DRUG ChloraPrep Hi-Lite Orange
- DRUG 3M CHG/IPA Prep Tint 10.5-mL
- DRUG 3M CHG/IPA Prep Tint 26-mL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 426 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01968707
The ClinicalTrials.gov registry entry for NCT01968707 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 426 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Normal saline is the first listed.
NCT01968707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01968707 about?
NCT01968707 is a clinical study titled "In-vivo Efficacy Study of Patient Pre-operative Preps". The purpose of this study is to determine the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.
What is the current status of trial NCT01968707?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 426 participants. The study started on 2013-10. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01968707?
The interventions under investigation include: Normal saline (DRUG), ChloraPrep Hi-Lite Orange (DRUG), 3M CHG/IPA Prep Tint 10.5-mL (DRUG), 3M CHG/IPA Prep Tint 26-mL (DRUG).
Who is sponsoring clinical trial NCT01968707?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.